The estimated Net Worth of Justin Leong is at least $15.2 Milion dollars as of 5 August 2024. Mr. Leong owns over 48,000 units of Resmed stock worth over $4,739,974 and over the last 4 years he sold RMD stock worth over $10,419,360. In addition, he makes $0 as President – Asia and Latin America at Resmed.
Justin has made over 3 trades of the Resmed stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 48,000 units of RMD stock worth $10,419,360 on 5 August 2024.
The largest trade he's ever made was selling 48,000 units of Resmed stock on 5 August 2024 worth over $10,419,360. On average, Justin trades about 6,431 units every 124 days since 2020. As of 5 August 2024 he still owns at least 18,741 units of Resmed stock.
You can see the complete history of Mr. Leong stock trades at the bottom of the page.
Justin M. W. Leong serves as President – Asia and Latin America of the Company. Justin was a director at London based investment firm Hg Capital from 2006 to 2012, responsible for acquisitions and portfolio management, and serving on the board of directors of several privately held European healthcare companies. He was a management consultant with Bain & Co. where he advised clients on growth strategies, operational improvement projects, mergers and acquisitions. Justin holds a bachelor of commerce and a bachelor of laws from the University of New South Wales, Sydney, and a master of business administration from the Harvard Business School.
Justin Leong is 43, he's been the President – Asia and Latin America of Resmed since 2020. There are 22 older and no younger executives at Resmed. The oldest executive at Resmed Inc. is Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD, 79, who is the Founder & Non-Exec. Chairman.
Over the last 23 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace oraz David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Resmed executives and other stock owners filed with the SEC include: